Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'GASTROINTESTINAL TOXICITY' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 138 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Wallace, JL
      Pathogenesis of NSAID-induced gastroduodenal mucosal injury

      BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
    2. Bazzoli, F; De Luca, L; Graham, DY
      Helicobacter pylori infection and the use of NSAIDs

      BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
    3. Jackson, CG
      Therapeutic potential of COX-2 inhibitors in arthritis

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    4. Oviedo, JA; Wolfe, MM
      Clinical potential of cyclo-oxygenase-2 inhibitors

      BIODRUGS
    5. Lapane, KL; Spooner, JJ; Pettitt, D
      The effect of nonsteroidal anti-inflammatory drugs on the use of gastroprotective medication in people with arthritis

      AMERICAN JOURNAL OF MANAGED CARE
    6. Cryer, B
      The importance of addressing the condition of nonsteroidal anti-inflammatory drug-related gastropathy - An interview with Byron Cryer, MD

      AMERICAN JOURNAL OF MANAGED CARE
    7. Khan, I; Al-Awadi, FM; Thomas, N
      In vivo inhibition of cyclooxygenase-2 by a selective phosphorothioated oligonucleotide

      ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT
    8. Borges, MS; Capriles-Hulett, A; Caballero-Fonseca, F; Perez, CR
      Tolerability to new COX-2 inhibitors in NSAID-sensitive patients with cutaneous reactions

      ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
    9. Bradley, JD
      Celecoxib and rofecoxib: A distinction with a difference?

      JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
    10. Francois, D
      Spin doctors

      JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
    11. Harris, CJ; Brater, DC
      Renal effects of cyclooxygenase-2 selective inhibitors

      CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
    12. Bates, DE; Lemaire, JB
      Possible celecoxib-induced gastroduodenal ulceration

      ANNALS OF PHARMACOTHERAPY
    13. Kanji, S; Dumo, P
      The effect of Helicobacter pylori eradication on NSAID-induced gastrointestinal toxicity

      ANNALS OF PHARMACOTHERAPY
    14. Rodriguez, LAG; Hernandez-Diaz, S
      Relative risk of upper gastrointestinal complications among users of acetaminophen and nonsteroidal anti-inflammatory drugs

      EPIDEMIOLOGY
    15. Dreiser, RL; Le Parc, JM; Velicitat, P; Lleu, PL
      Oral meloxicam is effective in acute sciatica: two randomised, double-blind trials versus placebo or diclofenac

      INFLAMMATION RESEARCH
    16. Lazzaroni, M; Anderloni, A; Porro, GB
      The effects on gastroduodenal mucosa of a new nonsteroidal anti-inflammatory drug, amtolmetin-guacyl, versus piroxicam in healthy volunteers: a short-term, double-blind, endoscopically controlled study

      EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
    17. Lanas, A
      Nonsteroidal anti-inflammatory drugs, low-dose aspirin, and potential waysof reducing the risk of complications

      EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
    18. Schmidt, H; Geisslinger, G
      Selective cyclooxygenase-2 inhibitor. Pharmacology and state of knowledge following commercial availability

      SCHMERZ
    19. Rainsford, KD
      The ever-emerging anti-inflammatories. Have there been any real advances?

      JOURNAL OF PHYSIOLOGY-PARIS
    20. Mandell, BF
      COX-2 inhibitors and cardiovascular risk - Point and counterpoint

      CLEVELAND CLINIC JOURNAL OF MEDICINE
    21. Cryer, B
      Mucosal defense and repair - Role of prostaglandins in the stomach and duodenum

      GASTROENTEROLOGY CLINICS OF NORTH AMERICA
    22. Houchen, CW
      Clinical implications of prostaglandin inhibition in the small bowel

      GASTROENTEROLOGY CLINICS OF NORTH AMERICA
    23. Simon, LS
      Cox-2 inhibitors - Are they nonsteroidal anti-inflammatory drugs with a better safety profile?

      GASTROENTEROLOGY CLINICS OF NORTH AMERICA
    24. Deray, G
      Renal tolerance to selective inhibitors of cyclooxygenase type 2

      PRESSE MEDICALE
    25. Bannwarth, B
      COX-2 specific inhibitors: Are NSAIDs and the stomach become reconciled?

      GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE
    26. Truitt, KE; Sperling, RS; Ettinger, WH; Greenwald, M; DeTora, L; Zeng, Q; Bolognese, J; Ehrich, E
      A multicenter, randomized, controlled trial to evaluate the safety profile, tolerability, and efficacy of rofecoxib in advanced elderly patients withosteoarthritis

      AGING-CLINICAL AND EXPERIMENTAL RESEARCH
    27. Abramson, SB
      Controversies in COX-2 inhibitor therapy - Introduction

      CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
    28. Hochberg, MC
      What have we learned from the large outcomes trials of COX-2 selective inhibitors? The rheumatologist's perspective

      CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
    29. FitzGerald, GA; Cheng, Y; Austin, S
      COX-2 inhibitors and the cardiovascular system

      CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
    30. Appel, GB
      COX-2 inhibitors and the kidney

      CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
    31. Patrono, C
      Measurement of cyclooxygenase isozyme inhibition in humans: exploring the clinical relevance of biochemical selectivity

      CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
    32. Day, RO
      Pharmacokinetic and pharmacodynamic aspects of the ideal COX-2 inhibitor: a rheumatologist's perspective

      CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
    33. Kulkarni, SK; Jain, NK; Singh, A
      Nitric oxide-releasing NSAIDs: a new dimension in nonsteroidal antiinflammatory drugs

      DRUGS OF THE FUTURE
    34. Parente, L
      Pros and cons of selective inhibition of cyclooxygenase-2 versus dual lipoxygenase/cyclooxygenase inhibition: Is two better than one?

      JOURNAL OF RHEUMATOLOGY
    35. Steinfeld, S; Poriau, S
      Patient and physician satisfaction with rofecoxib in osteoarthritis: Results of the EVA (experience with VIOXX in arthritis) survey

      CURRENT MEDICAL RESEARCH AND OPINION
    36. Komers, R; Anderson, S; Epstein, M
      Renal and cardiovascular effects of selective cyclooxygenase-2 inhibitors

      AMERICAN JOURNAL OF KIDNEY DISEASES
    37. Louw, JA; Marks, IN
      The medical treatment of peptic ulcer disease

      CURRENT OPINION IN GASTROENTEROLOGY
    38. Brater, DC; Harris, C; Redfern, JS; Gertz, BJ
      Renal effects of COX-2-selective inhibitors

      AMERICAN JOURNAL OF NEPHROLOGY
    39. Hachulla, E
      Specific inhibitors of Cox-2 and hemostasis the internists point of view

      REVUE DE MEDECINE INTERNE
    40. Dannhardt, G; Kiefer, W
      Cyclooxygenase inhibitors - current status and future prospects

      EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
    41. Luggen, M
      Treatment of rheumatic diseases in the elderly

      GERIATRIC NURSING
    42. Daniele, B; Rossi, GB; Losito, S; Gridelli, C; de Bellis, M
      Ischemic colitis associated with paclitaxel

      JOURNAL OF CLINICAL GASTROENTEROLOGY
    43. Johansson, JE; Soussi, B; Bagge, U; Ekman, T
      Disturbance of purine nucleotide metabolism - A possible early key event in development of intestinal damage induced by chemotherapy

      DIGESTIVE DISEASES AND SCIENCES
    44. Weaver, AL
      Rofecoxib: Clinical pharmacology and clinical experience

      CLINICAL THERAPEUTICS
    45. Harris, SI; Kuss, M; Hubbard, RC; Goldstein, JL
      Upper gastrointestinal safety evaluation of parecoxib sodium, a new parenteral cyclooxygenase-2-specific inhibitor, compared with ketorolac, naproxen, and placebo

      CLINICAL THERAPEUTICS
    46. Wilcock, M; MacKenzie, I
      Selective cyclo-oxygenase inhibitors

      LANCET
    47. Boers, M
      NSAIDS and selective COX-2 inhibitors: competition between gastroprotection and cardioprotection

      LANCET
    48. Emery, P; Hawkey, CJ; Moore, A
      Prescribing in the UK

      LANCET
    49. Pisetsky, DS; St Clair, EW
      Progress in the treatment of rheumatoid arthritis

      JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    50. Burnakis, TG
      Cardiovascular events and COX-2 inhibitors

      JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    51. Fleming, M
      Cardiovascular events and COX-2 inhibitors

      JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    52. Minic, M
      Cardiovascular events and COX-2 inhibitors

      JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    53. Steinmeyer, J
      Pharmacotherapy of osteoarthritis

      ORTHOPADE
    54. Bajwa, ZH; Gupta, S; Warfield, CA; Steinman, TI
      Pain management in polycystic kidney disease

      KIDNEY INTERNATIONAL
    55. Nies, AS; Gresser, MJ
      Cyclooxygenase-2 inhibitors

      ADVANCES IN PROTEIN CHEMISTRY, VOL 56
    56. Nasonov, EL
      Celebrex - confirmed effectiveness and safety (new data)

      TERAPEVTICHESKII ARKHIV
    57. Riedemann, JP; Illesca, M; Droghetti, J
      Self medication among patients with musculoskeletal symptoms

      REVISTA MEDICA DE CHILE
    58. FitzGerald, GA; Patrono, C
      Drug therapy: The coxibs, selective inhibitors of cyclooxygenase-2.

      NEW ENGLAND JOURNAL OF MEDICINE
    59. Fitzgerald, D; McCrory, C
      Pharmacology of COX-2 inhibition in man: Antiinflammatory and analgesic effects of nimesulide

      DRUGS OF TODAY
    60. Cleland, LG; James, MJ; Stamp, LK; Penglis, PS
      COX-2 inhibition and thrombotic tendency: a need for surveillance

      MEDICAL JOURNAL OF AUSTRALIA
    61. Brooks, PM
      Managing arthritis in the bone and joint decade

      MEDICAL JOURNAL OF AUSTRALIA
    62. Patrono, C; Patrignani, P; Rodriguez, LAG
      Cyclooxygenase-selective inhibition of prostanoid formation: transducing biochemical selectivity into clinical read-outs

      JOURNAL OF CLINICAL INVESTIGATION
    63. FitzGerald, GA; Loll, P
      COX in a crystal ball: current status and future promise of prostaglandin research

      JOURNAL OF CLINICAL INVESTIGATION
    64. Stichtenoth, DO; Frolich, JC
      Therapy with preferential and specific COX-2 inhibitors

      INTERNIST
    65. Il Kim, T; Lee, YC; Lee, KH; Han, JH; Chow, CY; Moon, YM; Kang, JK; Park, IS
      Effects of nonsteroidal anti-inflammatory drugs on Helicobacter pylori-infected gastric mucosae of mice: Apoptosis, cell proliferation, and inflammatory activity

      INFECTION AND IMMUNITY
    66. Sumen, G; Cimsit, M; Eroglu, L
      Hyperbaric oxygen treatment reduces carrageenan-induced acute inflammationin rats

      EUROPEAN JOURNAL OF PHARMACOLOGY
    67. Giuliano, F; Ferraz, JGP; Pereira, R; de Nucci, G; Warner, TD
      Cyclooxygenase selectivity of non-steroid anti-inflammatory drugs in humans: ex vivo evaluation

      EUROPEAN JOURNAL OF PHARMACOLOGY
    68. Matheson, AJ; Figgitt, DP
      Rofecoxib - A review of its use in the management of osteoarthritis, acutepain and rheumatoid arthritis

      DRUGS
    69. Jackson, DW; Simon, TM; Aberman, HM
      Symptomatic articular cartilage degeneration - The impact in the new millennium

      CLINICAL ORTHOPAEDICS AND RELATED RESEARCH
    70. Gupta, S; Crofford, LJ
      An update on specific COX-2 inhibitors: The COXIBs

      BULLETIN ON THE RHEUMATIC DISEASES
    71. Roy, HK; Karoski, WJ; Ratashak, A; Smyrk, TC
      Chemoprevention of intestinal tumorigenesis by nabumetone: induction of apoptosis and Bcl-2 downregulation

      BRITISH JOURNAL OF CANCER
    72. Simon, LS
      COX-2 inhibition: An advance or only pharmaceutical "hype"?

      ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH
    73. Brandt, KD
      A critique of the 2000 update of the American College of Rheumatology recommendations for management of hip and knee osteoarthritis

      ARTHRITIS AND RHEUMATISM
    74. Jawad, ASM
      Management of knee osteoarthritis - Author's reply

      ANNALS OF THE RHEUMATIC DISEASES
    75. Perazella, MA; Tray, K
      Selective cyclooxygenase-2 inhibitors: A pattern of nephrotoxicity similarto traditional nonsteroidal anti-inflammatory drugs

      AMERICAN JOURNAL OF MEDICINE
    76. Fennerty, MB; Triadafilopoulos, G
      Barrett's-related esophageal adenocarcinoma: Is chemoprevention a potential option?

      AMERICAN JOURNAL OF GASTROENTEROLOGY
    77. Moore, PA; Hersh, EV
      Celecoxib and rofecoxib - The role of COX-2 inhibitors in dental practice

      JOURNAL OF THE AMERICAN DENTAL ASSOCIATION
    78. Brinker, AD; Bonnel, RA; Feight, AG
      Celecoxib and rofecoxib

      JOURNAL OF THE AMERICAN DENTAL ASSOCIATION
    79. Moore, P; Hersh, EV
      Celecoxib and rofecoxib - Response

      JOURNAL OF THE AMERICAN DENTAL ASSOCIATION
    80. Tox, U; Goeser, T; Steffen, HM
      Ulcer prophylaxis in chronic treatment with steroids?

      DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT
    81. Wallace, JL
      How do NSAIDs cause ulcer disease?

      BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
    82. Haglund, U; Svarvar, P
      The Swedish ACCES model: predicting the health economic impact of celecoxib in patients with osteoarthritis or rheumatoid arthritis

      RHEUMATOLOGY
    83. Coruzzi, G
      New safer non-steroidal anti-inflammatory drugs?

      DRUG DISCOVERY TODAY
    84. Dajani, EZ; Klamut, MJ
      Novel therapeutic approaches to gastric and duodenal ulcers: an update

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    85. Saag, K; van der Heijde, D; Fisher, C; Samara, A; DeTora, L; Bolognese, J; Sperling, R; Daniels, B
      Rofecoxib, a new cyclooxygenase 2 inhibitor, shows sustained efficacy, comparable with other nonsteroidal anti-inflammatory drugs - A 6-week and a 1-year trial in patients with osteoarthritis

      ARCHIVES OF FAMILY MEDICINE
    86. Griffin, M
      Con: Nonsteroidal anti-inflammatory drugs should not be routinely administered for postoperative analgesia after cardiac surgery

      JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA
    87. Woo, PCY; Ng, WF; Leung, HCH; Tsoi, HW; Yuen, KY
      Clarithromycin attenuates cyclophosphamide-induced mucositis in mice

      PHARMACOLOGICAL RESEARCH
    88. van Ryn, J; Trummlitz, G; Pairet, M
      COX-2 selectivity and inflammatory processes

      CURRENT MEDICINAL CHEMISTRY
    89. Janero, DR
      Nitric oxide (NO)-related pharmaceuticals: Contemporary approaches to therapeutic NO modulation

      FREE RADICAL BIOLOGY AND MEDICINE
    90. Kulkarni, SK; Jain, NK; Singh, A
      Cyclooxygenase isoenzymes and newer therapeutic potential for selective COX-2 inhibitors

      METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY
    91. Yoshisue, K; Hironaga, K; Yamaguchi, S; Yamamoto, A; Nagayama, S; Kawaguchi, Y
      Reduction of 5-fluorouracil (5-FU) gastrointestinal (GI) toxicity resulting from the protection of thymidylate synthase (TS) in GI tissue by repeatedsimultaneous administration of potassium oxonate (Oxo) in rats

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    92. Pelosi, E; Masaneo, I; Clara, R; Valetto, MR; Bello, M; Zanon, C; Chiappino, I; Grosso, M; Mussa, A; Bisi, G
      Technetium-99m labelled macroaggregated albumin arterial catheter perfusion scintigraphy: prediction of gastrointestinal toxicity in hepatic arterialchemotherapy

      EUROPEAN JOURNAL OF NUCLEAR MEDICINE
    93. Martin, RM; Biswas, P; Mann, RD
      The incidence of adverse events and risk factors for upper gastrointestinal disorders associated with meloxicam use amongst 19087 patients in generalpractice in England: cohort study

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    94. Macnaughton, WK
      Review article: new insights into the pathogenesis of radiation-induced intestinal dysfunction

      ALIMENTARY PHARMACOLOGY & THERAPEUTICS
    95. Kimura, Y; Baba, K; Okuda, H
      Inhibitory effects of active substances isolated from Cassia garrettiana heartwood on tumor growth and lung metastasis in Lewis lung carcinoma-bearing mice (part 1)

      ANTICANCER RESEARCH
    96. Kimura, Y; Okuda, H
      Effects of naturally occurring stilbene glucosides from medicinal plants and wine, on tumour growth and lung metastasis in Lewis lung carcinoma-bearing mice

      JOURNAL OF PHARMACY AND PHARMACOLOGY
    97. Wallace, JL; McKnight, W; Reuter, BK; Vergnolle, N
      NSAID-induced gastric damage in rats: Requirement for inhibition of both cyclooxygenase 1 and 2

      GASTROENTEROLOGY
    98. Blot, L; Marcelis, A; Devogelaer, JP; Manicourt, DH
      Effects of diclofenac, aceclofenac and meloxicam on the metabolism of proteoglycans and hyaluronan in osteoarthritic human cartilage

      BRITISH JOURNAL OF PHARMACOLOGY
    99. van Dieten, HEM; Korthals-de Bos, IBC; van Tulder, MW; Lems, WF; Dijkmans, BAC; Boers, M
      Systematic review of the cost effectiveness of prophylactic treatments in the prevention of gastropathy in patients with rheumatoid arthritis or osteoarthritis taking non-steroidal anti-inflammatory drugs

      ANNALS OF THE RHEUMATIC DISEASES
    100. Jones, CJ; Budsberg, SC
      Physiologic characteristics and clinical importance of the cyclooxygenase isoforms in dogs and cats

      JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 18/02/20 alle ore 05:28:37